Patents by Inventor Karolina Nilsson

Karolina Nilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Flexible medical supports
    Patent number: 10555857
    Abstract: A patient support is provided with a membrane made of a stretchable material. The membrane may be fixed in one embodiment to lateral supports and used as a patient's knee or calf support. During use, the membrane can stretch on the application of force by a patient, which stretch will reduce discomfort and pain and can also assist in preventing slippage of the patient during movement. The flexible membrane may be used also in patient slings and other supports.
    Type: Grant
    Filed: September 26, 2015
    Date of Patent: February 11, 2020
    Assignee: Arjo IP Holding AB
    Inventors: Mimmi Anderberg, Per Ekelin, Marcus Johansson, Marie Rubin, Thomas Nilsson, Karolina Nilsson
  • FLEXIBLE MEDICAL SUPPORTS
    Publication number: 20160184151
    Abstract: A patient support is provided with a membrane made of a stretchable material. The membrane may be fixed in one embodiment to lateral supports and used as a patient's knee or calf support. During use, the membrane can stretch on the application of force by a patient, which stretch will reduce discomfort and pain and can also assist in preventing slippage of the patient during movement. The flexible membrane may be used also in patient slings and other supports.
    Type: Application
    Filed: September 26, 2015
    Publication date: June 30, 2016
    Applicant: ARJO HOSPITAL EQUIPMENT AB
    Inventors: Mimmi ANDERBERG, Per EKELIN, Marcus JOHANSSON, Marie RUBIN, Thomas NILSSON, Karolina NILSSON
  • Imidazole variants as modulators of GABA receptor for the treatment of GI disorders
    Patent number: 7718686
    Abstract: The present invention relates to novel compounds having a positive allosteric GÀBAB receptor (GDR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABAB agonist, for the inhibition of transient lower esophageal sphincter relaxations, for the treatment of gastroesophageal reflux disease, as well as for the treatment of functional gastrointestinal disorders and irritable bowel syndrome (IBS). A compound of the general formula I.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: May 18, 2010
    Assignee: AstraZeneca AB
    Inventors: Udo Bauer, Wayne Brailsford, Vijay Chhajlani, Bryan Egner, Ola Fjellström, Linda Gustafsson, Jan Mattsson, Karolina Nilsson, Thomas Olsson
  • MGluR5 modulators I
    Patent number: 7678796
    Abstract: The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
    Type: Grant
    Filed: April 25, 2007
    Date of Patent: March 16, 2010
    Assignee: AstraZeneca AB
    Inventors: Andreas Wallberg, Karolina Nilsson, Björn Holm, Mats Nagard, Kenneth Granberg, Abdelmalik Slassi, Louise Edwards, Methvin Isaac, Tao Xin, Tomislav Stefanac
  • Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides
    Publication number: 20090181968
    Abstract: The present invention relates to compounds of formula (I) [Chemical formula should be inserted here. Please see paper copy] as well as pharmaceutically acceptable salts and pharmaceutical compositions including the compounds are prepared or thereof: wherein, A1, A2, R1, R2, R3, R4, and R5 and n are as defined in the specification. The compounds of formula (I) are useful in therapy.
    Type: Application
    Filed: November 22, 2006
    Publication date: July 16, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Kosrat Amin, Johan Broddefalk, Yantao Chen, Karolina Nilsson, Claire Milburn, Helene Desfosses, Ziping Liu, Maxime Tremblay, Christopher Walpole, Zhong-yong Wei, Hua Yang
  • Imidazole Variants as Modulators of Gaba Receptor For the Treatment of Gi Disorders
    Publication number: 20080269216
    Abstract: The present invention relates to novel compounds having a positive allosteric GÀBAB receptor (GDR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABAB agonist, for the inhibition of transient lower esophageal sphincter relaxations, for the treatment of gastroesophageal reflux disease, as well as for the treatment of functional gastrointestinal disorders and irritable bowel syndrome (IBS).
    Type: Application
    Filed: June 20, 2005
    Publication date: October 30, 2008
    Inventors: Udo Bauer, Wayne Brailsford, Vijay Chhajlani, Bryan Egner, Ola Fjellstrom, Linda Gustafsson, Jan Mattsson, Karolina Nilsson, Thomas Olsson
  • MGluR5 modulators I
    Publication number: 20070259862
    Abstract: The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
    Type: Application
    Filed: April 25, 2007
    Publication date: November 8, 2007
    Applicants: AstraZeneca AB, NPS PHARMACEUTICALS, INC.
    Inventors: Andreas Wallberg, Karolina Nilsson, Bjorn Holm, Mats Nagard, Kenneth Granberg, Abdelmalik Slassi, Louise Edwards, Methvin Isaac, Tao Xin, Tomislav Stefanac
  • MGluR5 modulators V
    Publication number: 20070259860
    Abstract: The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
    Type: Application
    Filed: April 25, 2007
    Publication date: November 8, 2007
    Applicants: AstraZeneca AB, NPS PHARMACEUTICALS, INC.
    Inventors: Andreas Wallberg, Karolina Nilsson, Kenneth Granberg, Saswati Ghosal, Abdelmalik Slassi, Louise Edwards, Methvin Isaac, Tao Xin, Tomislav Stefanac, Peter Dove
  • Therapeutic Compounds: Pyridine as Scaffold
    Publication number: 20070225292
    Abstract: Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, n and A are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: May 20, 2005
    Publication date: September 27, 2007
    Inventors: Kosrat Amin, Johan Broddefalk, Helene Desfosses, Emma Evertsson, Ziping Liu, Claire Milburn, Karolina Nilsson, Maxime Tremblay, Christopher Walpole, Zhong-yong Wei, Hua Yang